Document is current

Article History

Accepted: 4 November 2024

First Online: 5 December 2024

Declarations

:

: Open access funding provided by Université Toulouse III - Paul Sabatier. The authors have not declared a specific grant for this research from any funding agency in the public, commercial, or not-for-profit sectors.

: No commercial organizations had any role in the writing of this paper for publication. All authors declare they have no conflicts of interest.

: The study was conducted in accordance with the principles of the Declaration of Helsinki. Patient consent was not required because the analysis was carried out on the French Pharmacovigilance DataBase, an anonymized database.

: Patient consent was waived as the French Pharmacovigilance database contains anonymised data that cannot allow patients’ identification.

: Not applicable.

: Data sharing is not applicable to this article, as the datasets used are based on anonymised data that are protected by agreements with the French Data Protection Commission (CNIL; Commission Nationale de l’Informatique et Liberté).

: The code will be made available upon reasonable request to the corresponding author.

: D.B., H.B. and H.T.-V. contributed equally to this study. They had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. D.B. and H.B. conceptualized the study. D.B., H.B. and F.S. designed the study. All authors were involved in acquisition, analysis, and interpretation of the data. M.B.R., H.G., M.L., F.R., J.M. and A.G. provided administrative, technical or material support. D.B., H.B. and H.T.-V. drafted the manuscript. All authors read and approved the final version.